Quorum Health Corporation, together with its subsidiaries, provides hospital and outpatient healthcare services in the United States. Its hospital and outpatient healthcare services include general and acute care, emergency room, general and specialty surgery, critical care, internal medicine, diagnostic, obstetric, psychiatric, and rehabilitation services.
Read More…
Industry, Sector and Symbol
Industry General medical & surgical hospitals
Sub-IndustryN/A
SectorMedical
Phone615-221-1400
Debt
Price-To-Earnings
Sales & Book Value
Annual Sales$1.88 billion
Profitability
Miscellaneous
Employees11,600
Next Earnings Date11/5/2019 (Estimated)
OptionableOptionable
Quorum Health (NYSE:QHC) Frequently Asked Questions
What is Quorum Health's stock symbol?
Quorum Health trades on the New York Stock Exchange (NYSE) under the ticker symbol "QHC."
How were Quorum Health's earnings last quarter?
Quorum Health Corp (NYSE:QHC) released its quarterly earnings data on Wednesday, August, 7th. The company reported ($0.38) earnings per share for the quarter, missing the Thomson Reuters' consensus estimate of ($0.36) by $0.02. The firm earned $442.17 million during the quarter, compared to analyst estimates of $475.01 million. Quorum Health's quarterly revenue was down 6.4% compared to the same quarter last year. During the same quarter in the previous year, the business earned ($0.33) EPS. View Quorum Health's Earnings History.
When is Quorum Health's next earnings date?
What price target have analysts set for QHC?
1 brokerages have issued 12-month price targets for Quorum Health's stock. Their predictions range from $2.00 to $2.00. On average, they expect Quorum Health's share price to reach $2.00 in the next twelve months. This suggests a possible upside of 88.7% from the stock's current price. View Analyst Price Targets for Quorum Health.
What is the consensus analysts' recommendation for Quorum Health?
1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Quorum Health in the last year. There are currently 1 hold rating for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for Quorum Health.
Has Quorum Health been receiving favorable news coverage?
Media stories about QHC stock have been trending positive this week, according to InfoTrie Sentiment Analysis. The research group scores the sentiment of press coverage by analyzing more than six thousand news and blog sources in real-time. The firm ranks coverage of public companies on a scale of negative five to five, with scores nearest to five being the most favorable. Quorum Health earned a daily sentiment score of 2.5 on InfoTrie's scale. They also assigned news articles about the company a news buzz of 6.0 out of 10, indicating that recent press coverage is somewhat likely to have an impact on the stock's share price in the next few days. View News Stories for Quorum Health.
Who are some of Quorum Health's key competitors?
What other stocks do shareholders of Quorum Health own?
Who are Quorum Health's key executives?
Quorum Health's management team includes the folowing people:
- Mr. Martin D. Smith, Exec. VP & COO (Age 51)
- Mr. Ray Harold McCard Jr., Sr. VP, Gen. Counsel & Sec. (Age 57)
- Mr. Michael J. Culotta, Consultant (Age 64)
- Mr. Robert H. Fish, Pres, CEO & Director (Age 68)
- Mr. Alfred Lumsdaine, Exec. VP & CFO (Age 54)
Who are Quorum Health's major shareholders?
Quorum Health's stock is owned by many different of retail and institutional investors. Top institutional investors include Vanguard Group Inc. (5.67%), Renaissance Technologies LLC (1.65%), BlackRock Inc. (1.57%), Northern Trust Corp (0.92%), Invesco Ltd. (0.53%) and Paloma Partners Management Co (0.41%). View Institutional Ownership Trends for Quorum Health.
Which institutional investors are selling Quorum Health stock?
QHC stock was sold by a variety of institutional investors in the last quarter, including BlackRock Inc., D. E. Shaw & Co. Inc., Bank of New York Mellon Corp, Charles Schwab Investment Management Inc., SG Americas Securities LLC, Invesco Ltd. and Northern Trust Corp. View Insider Buying and Selling for Quorum Health.
Which institutional investors are buying Quorum Health stock?
QHC stock was purchased by a variety of institutional investors in the last quarter, including Renaissance Technologies LLC, Vanguard Group Inc., Jane Street Group LLC, Paloma Partners Management Co, A.R.T. Advisors LLC and KBC Group NV. View Insider Buying and Selling for Quorum Health.
How do I buy shares of Quorum Health?
Shares of QHC can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is Quorum Health's stock price today?
One share of QHC stock can currently be purchased for approximately $1.06.
How big of a company is Quorum Health?
Quorum Health has a market capitalization of $34.88 million and generates $1.88 billion in revenue each year. The company earns $-200,250,000.00 in net income (profit) each year or ($1.64) on an earnings per share basis. Quorum Health employs 11,600 workers across the globe.View Additional Information About Quorum Health.
What is Quorum Health's official website?
How can I contact Quorum Health?
Quorum Health's mailing address is 1573 MALLORY LANE, BRENTWOOD TN, 37027. The company can be reached via phone at 615-221-1400 or via email at [email protected]
MarketBeat Community Rating for Quorum Health (NYSE QHC)
MarketBeat's community ratings are surveys of what our community members think about Quorum Health and other stocks. Vote "Outperform" if you believe QHC will outperform the S&P 500 over the long term. Vote "Underperform" if you believe QHC will underperform the S&P 500 over the long term. You may vote once every thirty days.
